Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2026-01-04 @ 3:41 AM
Study NCT ID:
NCT05111366
Status:
UNKNOWN
Last Update Posted:
2022-05-04
First Post:
2021-10-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection
Sponsor:
Xianhai Mao
Organization: